Thuja invests in Salvia BioElectronics
22 May 2018, Eindhoven – Salvia BioElectronics B.V. announced today that it secured € 1.3 million in seed funding to develop a minimally invasive bioelectronics solution for people suffering from chronic neurological disease. (more…)
Thuja Capital exits NightBalance to Philips
8 May, 2018, Utrecht, The Netherlands – Thuja Capital announced it has sold its shareholding in NightBalance B.V. (The Hague, Netherlands) to Royal Philips (NYSE: PHG, AEX: PHIA). (more…)
NutriLeads wins EUR 2.5M Horizon2020 SME funding
March 29, Wageningen, The Netherlands. NutriLeads, a Dutch Health Ingredients company announces that its NUTRI-NEED project has been selected for €2.5 million funding under the European Innovation Council SME Instrument (phase 2). (more…)
Hemics in the news
21 February 2018 – A nice overview was published on recent developments within the rheumatoid arthritis diagnostics space. Please find the article here. (English language).